» Articles » PMID: 38409551

Ubiquitin Specific Peptidase 38 Epigenetically Regulates KLF Transcription Factor 5 to Augment Malignant Progression of Lung Adenocarcinoma

Overview
Journal Oncogene
Date 2024 Feb 27
PMID 38409551
Authors
Affiliations
Soon will be listed here.
Abstract

Protein ubiquitination is a common post-translational modification and a critical mechanism for regulating protein stability. This study aimed to explore the role and potential molecular mechanism of ubiquitin-specific peptidase 38 (USP38) in the progression of lung adenocarcinoma (LUAD). USP38 expression was significantly higher in patients with LUAD than in their counterparts, and higher USP38 expression was closely associated with a worse prognosis. USP38 silencing suppresses the proliferation of LUAD cells in vitro and impedes the tumorigenic activity of cells in xenograft mouse models in vivo. Further, we found that USP38 affected the protein stability of transcription factor Krüppel-like factors 5 (KLF5) by inhibiting its degradation. Subsequent mechanistic investigations showed that the N-terminal of USP38 (residues 1-400aa) interacted with residues 1-200aa of KLF5, thereby stabilizing the KLF5 protein by deubiquitination. Moreover, we found that PIAS1-mediated SUMOylation of USP38 was promoted, whereas SENP2-mediated de-SUMOylation of USP38 suppressed the deubiquitination effects of USP38 on KLF5. Additionally, our results demonstrated that KLF5 overexpression restored the suppression of the malignant properties of LUAD cells by USP38 knockdown. SUMOylation of USP38 enhances the deubiquitination and stability of KLF5, thereby augmenting the malignant progression of LUAD.

Citing Articles

Porphyromonas gingivalis potentiates stem-like properties of oral squamous cell carcinoma by modulating SCD1-dependent lipid synthesis via NOD1/KLF5 axis.

Zang W, Geng F, Liu J, Wang Z, Zhang S, Li Y Int J Oral Sci. 2025; 17(1):15.

PMID: 40016182 PMC: 11868650. DOI: 10.1038/s41368-024-00342-8.


USP38 functions as an oncoprotein by downregulating the p53 pathway through deubiquitination and stabilization of MDM2.

Zhao S, Liu X, Luo R, Jian Z, Xu C, Hou Y Cell Death Differ. 2025; .

PMID: 39987355 DOI: 10.1038/s41418-025-01462-2.


Deubiquitinases as novel therapeutic targets for diseases.

Xian Y, Ye J, Tang Y, Zhang N, Peng C, Huang W MedComm (2020). 2024; 5(12):e70036.

PMID: 39678489 PMC: 11645450. DOI: 10.1002/mco2.70036.


LN-439A, a novel BAP1 inhibitor, suppresses the growth of basal-like breast cancer by degrading KLF5.

Wang T, Zhang L, Li F, Zhang J, Zhang Z, Mi D Acta Pharmacol Sin. 2024; 46(3):715-727.

PMID: 39379684 PMC: 11845570. DOI: 10.1038/s41401-024-01361-1.

References
1.
Herbst R, Morgensztern D, Boshoff C . The biology and management of non-small cell lung cancer. Nature. 2018; 553(7689):446-454. DOI: 10.1038/nature25183. View

2.
Reck M, Heigener D, Mok T, Soria J, Rabe K . Management of non-small-cell lung cancer: recent developments. Lancet. 2013; 382(9893):709-19. DOI: 10.1016/S0140-6736(13)61502-0. View

3.
Magiera M, Singh P, Janke C . SnapShot: Functions of Tubulin Posttranslational Modifications. Cell. 2018; 173(6):1552-1552.e1. DOI: 10.1016/j.cell.2018.05.032. View

4.
Hochstrasser M . Origin and function of ubiquitin-like proteins. Nature. 2009; 458(7237):422-9. PMC: 2819001. DOI: 10.1038/nature07958. View

5.
Gallo L, Ko J, Donoghue D . The importance of regulatory ubiquitination in cancer and metastasis. Cell Cycle. 2017; 16(7):634-648. PMC: 5397262. DOI: 10.1080/15384101.2017.1288326. View